WCO 分类路径
- 章30药品
- 品目3002人血、动物血；抗血清、免疫制品；疫苗、毒素及培养物AI 译
- 子目300213未混合免疫制品，非零售或定量包装AI 译
- 国家码30021300- - Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
30021300
"- - Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale"
HS 编码 30021300（第 30 章「药品」；品目 3002「人血、动物血；抗血清、免疫制品；疫苗、毒素及培养物」；子目 300213「未混合免疫制品，非零售或定量包装」）在印度尼西亚税则中对应"- - Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale"。印度尼西亚海关对该编码商品征收MFN 进口税 0.00、增值税 (PPN) 12.00。该商品涉及 14 项进口管理规定或禁限措施，详见合规章节。目前有 19 项自贸协定优惠税率可适用于该编码。
税率清单
| 类别 | 税率 |
|---|---|
MFN 进口税 Import duty (MFN) | 0.00 |
增值税 (PPN) VAT (PPN) | 12.00 |
自贸协定优惠税率
19 项特惠可选 · 需原产地证明
| 协定 / 特惠 | 税率 |
|---|---|
| AANZFTA (ASEAN Australia New Zealand Free Trade Agreement) | 0% |
| ACFTA (ASEAN - China Free Trade Area) | 0% |
| AHKFTA (ASEAN-Hong Kong Free Trade Agreement) | 0% |
| AIFTA (ASEAN India Free Trade Agreement) | 0% |
| AJCEP (ASEAN-Japan Comprehensive Economic Partnership) | 0% |
| AKFTA (ASEAN Korea Free Trade Agreement) | 0% |
| ATIGA (ASEAN Trade in Goods Agreement) | 0% |
| IACEPA (Indonesia-Australia Comprehensive Economic Partnership Agreement) | 0% |
| ICCEPA (Indonesia-Chile Comprehensive Economic Partnership Agreement) | 0% |
| IECEPA (Indonesia-European Free Trade Association Comprehensive Economic Parthership) | 0% |
| IJEPA (Indonesia - Japan Economic Partnership Agreement) | 0% |
| IKCEPA (Indonesia-Korea Comprehensive Partnership Agreement) | 0% |
| IUAE-CEPA (Indonesia–United Arab Emirates Comprehensive Economic Partnership Agreement) | 0% |
| RCEP-ASEAN (Regional Comprehensive Economic Partnership Agreement - ASEAN) | 0% |
| RCEP-Australia (Regional Comprehensive Economic Partnership Agreement - Australia) | 0% |
| RCEP-China (Regional Comprehensive Economic Partnership Agreement - China) | 0% |
| RCEP-Japan (Regional Comprehensive Economic Partnership Agreement - Japan) | 0% |
| RCEP-Korea (Regional Comprehensive Economic Partnership Agreement - Korea) | 0% |
| RCEP-New Zealand (Regional Comprehensive Economic Partnership Agreement - New Zealand) | 0% |
合规与管制
14 项进口管理规定 / 禁限 / 许可证要求
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Produk imunologi, tidak dicampur, tidak disiapkan dalam dosis atau bentuk atau kemasan untuk penjualan eceran : Alpha Globulins (CAS Number 9006-79-5); Anti-Lymphocyte Immunoglobulin (Horse); Anti-Thymocyt Igg-Globulin (H[St) (CAS Number 308067-60-9); Basiliximabum (CAS Number 179045-86-4); Bevacizumab (CAS Number 216974-75-3); Bamlanivimab (CAS Number 2423943-37-5); Candida Antigen; Clostridium Botulinum Type A-Antitoxin; Etanercept(Tnfr : Fc) (CAS Number 185243-69- 0); Etesevimab (CAS Number 2423948-94-9); Gamma Globulin (CAS Number 9007-83-4); Granulocyte Colony Stimulating Factor (CAS Number 143011-72-7); Human Immunglobulin Anti-Hbs; Immunoglobulin Antihepatitis B; Immunoglobulin Human Anti-Tetanus; Immunoglobulin Human Normal; Immunoglobulin IgG2a; Immunoglobulin; Interferon Alfa; Interferon Alfa-2a (CAS Number 76543-88-9); Interferon Alfa-2b (CAS Number 98530-12-2); Interferon Beta; Interferon Beta-1a (CAS Number 145258-61-3); Interferon Lymphoblastoid Human; Interferon (CAS Number 9008-11-1); Intrinsic Factor (CAS number 9008-12-2); Iodinated (I-125) Fibrinogen; Lenograstim (CAS Number 135968-09-1); Methoxy Polyethylene Glycol Epoetin Beta (CAS Number 677324-53-7); Muromonab-Cd3 (CAS Number 140608-64-6); Peginterferon Alfa 2a (CAS Number 198153-51-4); Peg-Interferon Alfa-2b (CAS Number 215647-85-1); Pertactin (CAS Number 148374-88-3); Proteus Antigen; Rabies Antiserum; Rabies Imunoglobuline; Ranibizumab (CAS Number 347396-82-1); Regdanvimab (CAS Number 2444308-95-4); Rituximab (CAS Number 174722-31-7); Thrombin (CAS Number 9002-04-4); Thymosin Alpha-1 (CAS Number 62304-98-7); Trastuzumab (CAS Number 180288-69-1); Trichophyt Antigen; Tuberculin Ppd; Erenumab (CAS Number 1582205-90-0); Denosumab (CAS Number 615258-40-7); Obinutuzumab (CAS Number 949142-50-1); Triptorelin Acetate (CAS Number 140194-24-7); Eptinezumab (CAS Number 1644539-04-7); Evolocumab (CAS Number 1256937-27-5); Faricimab (CAS Number 1607793-29-2); Casirivimab (CAS Number 2415933-42-3); Serplulimab (CAS Number 2231029-82-4)
(KH.5, KH.7, KH.14, KH.17 atau KH.9a)
Darah Manusia; Darah Hewan Disiapkan Untuk Keperluan Terapeutik, Profilaktik Atau Diagnosis; Antiserum, Bagian Darah Dan Produk Imunologi Lainnya, Dimodifikasi Maupun Tidak Atau Diperoleh Dengan Proses Bioteknologi Maupun Tidak; Vaksin, Toksin, Kultur Dar
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Produk imunologi, tidak dicampur, tidak disiapkan dalam dosis atau bentuk atau kemasan untuk penjualan eceran : Alpha Globulins (CAS Number 9006-79-5); Anti-Lymphocyte Immunoglobulin (Horse); Anti-Thymocyt Igg-Globulin (H[St) (CAS Number 308067-60-9); Basiliximabum (CAS Number 179045-86-4); Bevacizumab (CAS Number 216974-75-3); Bamlanivimab (CAS Number 2423943-37-5); Candida Antigen; Clostridium Botulinum Type A-Antitoxin; Etanercept(Tnfr : Fc) (CAS Number 185243-69- 0); Etesevimab (CAS Number 2423948-94-9); Gamma Globulin (CAS Number 9007-83-4); Granulocyte Colony Stimulating Factor (CAS Number 143011-72-7); Human Immunglobulin Anti-Hbs; Immunoglobulin Antihepatitis B; Immunoglobulin Human Anti-Tetanus; Immunoglobulin Human Normal; Immunoglobulin IgG2a; Immunoglobulin; Interferon Alfa; Interferon Alfa-2a (CAS Number 76543-88-9); Interferon Alfa-2b (CAS Number 98530-12-2); Interferon Beta; Interferon Beta-1a (CAS Number 145258-61-3); Interferon Lymphoblastoid Human; Interferon (CAS Number 9008-11-1); Intrinsic Factor (CAS number 9008-12-2); Iodinated (I-125) Fibrinogen; Lenograstim (CAS Number 135968-09-1); Methoxy Polyethylene Glycol Epoetin Beta (CAS Number 677324-53-7); Muromonab-Cd3 (CAS Number 140608-64-6); Peginterferon Alfa 2a (CAS Number 198153-51-4); Peg-Interferon Alfa-2b (CAS Number 215647-85-1); Pertactin (CAS Number 148374-88-3); Proteus Antigen; Rabies Antiserum; Rabies Imunoglobuline; Ranibizumab (CAS Number 347396-82-1); Regdanvimab (CAS Number 2444308-95-4); Rituximab (CAS Number 174722-31-7); Thrombin (CAS Number 9002-04-4); Thymosin Alpha-1 (CAS Number 62304-98-7); Trastuzumab (CAS Number 180288-69-1); Trichophyt Antigen; Tuberculin Ppd; Erenumab (CAS Number 1582205-90-0); Denosumab (CAS Number 615258-40-7); Obinutuzumab (CAS Number 949142-50-1); Triptorelin Acetate (CAS Number 140194-24-7); Eptinezumab (CAS Number 1644539-04-7); Evolocumab (CAS Number 1256937-27-5); Faricimab (CAS Number 1607793-29-2); Casirivimab (CAS Number 2415933-42-3); Serplulimab (CAS Number 2231029-82-4)
(KH.5, KH.7, KH.14, KH.17 atau KH.9a)
Darah Manusia; Darah Hewan Disiapkan Untuk Keperluan Terapeutik, Profilaktik Atau Diagnosis; Antiserum, Bagian Darah Dan Produk Imunologi Lainnya, Dimodifikasi Maupun Tidak Atau Diperoleh Dengan Proses Bioteknologi Maupun Tidak; Vaksin, Toksin, Kultur Dar
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Produk imunologi, tidak dicampur, tidak disiapkan dalam dosis atau bentuk atau kemasan untuk penjualan eceran : Alpha Globulins (CAS Number 9006-79-5); Anti-Lymphocyte Immunoglobulin (Horse); Anti-Thymocyt Igg-Globulin (H[St) (CAS Number 308067-60-9); Basiliximabum (CAS Number 179045-86-4); Bevacizumab (CAS Number 216974-75-3); Bamlanivimab (CAS Number 2423943-37-5); Candida Antigen; Clostridium Botulinum Type A-Antitoxin; Etanercept(Tnfr : Fc) (CAS Number 185243-69- 0); Etesevimab (CAS Number 2423948-94-9); Gamma Globulin (CAS Number 9007-83-4); Granulocyte Colony Stimulating Factor (CAS Number 143011-72-7); Human Immunglobulin Anti-Hbs; Immunoglobulin Antihepatitis B; Immunoglobulin Human Anti-Tetanus; Immunoglobulin Human Normal; Immunoglobulin IgG2a; Immunoglobulin; Interferon Alfa; Interferon Alfa-2a (CAS Number 76543-88-9); Interferon Alfa-2b (CAS Number 98530-12-2); Interferon Beta; Interferon Beta-1a (CAS Number 145258-61-3); Interferon Lymphoblastoid Human; Interferon (CAS Number 9008-11-1); Intrinsic Factor (CAS number 9008-12-2); Iodinated (I-125) Fibrinogen; Lenograstim (CAS Number 135968-09-1); Methoxy Polyethylene Glycol Epoetin Beta (CAS Number 677324-53-7); Muromonab-Cd3 (CAS Number 140608-64-6); Peginterferon Alfa 2a (CAS Number 198153-51-4); Peg-Interferon Alfa-2b (CAS Number 215647-85-1); Pertactin (CAS Number 148374-88-3); Proteus Antigen; Rabies Antiserum; Rabies Imunoglobuline; Ranibizumab (CAS Number 347396-82-1); Regdanvimab (CAS Number 2444308-95-4); Rituximab (CAS Number 174722-31-7); Thrombin (CAS Number 9002-04-4); Thymosin Alpha-1 (CAS Number 62304-98-7); Trastuzumab (CAS Number 180288-69-1); Trichophyt Antigen; Tuberculin Ppd; Erenumab (CAS Number 1582205-90-0); Denosumab (CAS Number 615258-40-7); Obinutuzumab (CAS Number 949142-50-1); Triptorelin Acetate (CAS Number 140194-24-7); Eptinezumab (CAS Number 1644539-04-7); Evolocumab (CAS Number 1256937-27-5); Faricimab (CAS Number 1607793-29-2); Casirivimab (CAS Number 2415933-42-3); Serplulimab (CAS Number 2231029-82-4)
(KH.5, KH.7, KH.14, KH.17 atau KH.9a)
Darah Manusia; Darah Hewan Disiapkan Untuk Keperluan Terapeutik, Profilaktik Atau Diagnosis; Antiserum, Bagian Darah Dan Produk Imunologi Lainnya, Dimodifikasi Maupun Tidak Atau Diperoleh Dengan Proses Bioteknologi Maupun Tidak; Vaksin, Toksin, Kultur Dar
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Produk imunologi, tidak dicampur, tidak disiapkan dalam dosis atau bentuk atau kemasan untuk penjualan eceran : Alpha Globulins (CAS Number 9006-79-5); Anti-Lymphocyte Immunoglobulin (Horse); Anti-Thymocyt Igg-Globulin (H[St) (CAS Number 308067-60-9); Basiliximabum (CAS Number 179045-86-4); Bevacizumab (CAS Number 216974-75-3); Bamlanivimab (CAS Number 2423943-37-5); Candida Antigen; Clostridium Botulinum Type A-Antitoxin; Etanercept(Tnfr : Fc) (CAS Number 185243-69- 0); Etesevimab (CAS Number 2423948-94-9); Gamma Globulin (CAS Number 9007-83-4); Granulocyte Colony Stimulating Factor (CAS Number 143011-72-7); Human Immunglobulin Anti-Hbs; Immunoglobulin Antihepatitis B; Immunoglobulin Human Anti-Tetanus; Immunoglobulin Human Normal; Immunoglobulin IgG2a; Immunoglobulin; Interferon Alfa; Interferon Alfa-2a (CAS Number 76543-88-9); Interferon Alfa-2b (CAS Number 98530-12-2); Interferon Beta; Interferon Beta-1a (CAS Number 145258-61-3); Interferon Lymphoblastoid Human; Interferon (CAS Number 9008-11-1); Intrinsic Factor (CAS number 9008-12-2); Iodinated (I-125) Fibrinogen; Lenograstim (CAS Number 135968-09-1); Methoxy Polyethylene Glycol Epoetin Beta (CAS Number 677324-53-7); Muromonab-Cd3 (CAS Number 140608-64-6); Peginterferon Alfa 2a (CAS Number 198153-51-4); Peg-Interferon Alfa-2b (CAS Number 215647-85-1); Pertactin (CAS Number 148374-88-3); Proteus Antigen; Rabies Antiserum; Rabies Imunoglobuline; Ranibizumab (CAS Number 347396-82-1); Regdanvimab (CAS Number 2444308-95-4); Rituximab (CAS Number 174722-31-7); Thrombin (CAS Number 9002-04-4); Thymosin Alpha-1 (CAS Number 62304-98-7); Trastuzumab (CAS Number 180288-69-1); Trichophyt Antigen; Tuberculin Ppd; Erenumab (CAS Number 1582205-90-0); Denosumab (CAS Number 615258-40-7); Obinutuzumab (CAS Number 949142-50-1); Triptorelin Acetate (CAS Number 140194-24-7); Eptinezumab (CAS Number 1644539-04-7); Evolocumab (CAS Number 1256937-27-5); Faricimab (CAS Number 1607793-29-2); Casirivimab (CAS Number 2415933-42-3); Serplulimab (CAS Number 2231029-82-4)
(KH.5, KH.7, KH.14, KH.17 atau KH.9a)
Darah Manusia; Darah Hewan Disiapkan Untuk Keperluan Terapeutik, Profilaktik Atau Diagnosis; Antiserum, Bagian Darah Dan Produk Imunologi Lainnya, Dimodifikasi Maupun Tidak Atau Diperoleh Dengan Proses Bioteknologi Maupun Tidak; Vaksin, Toksin, Kultur Dar
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Produk imunologi, tidak dicampur, tidak disiapkan dalam dosis atau bentuk atau kemasan untuk penjualan eceran : Alpha Globulins (CAS Number 9006-79-5); Anti-Lymphocyte Immunoglobulin (Horse); Anti-Thymocyt Igg-Globulin (H[St) (CAS Number 308067-60-9); Basiliximabum (CAS Number 179045-86-4); Bevacizumab (CAS Number 216974-75-3); Bamlanivimab (CAS Number 2423943-37-5); Candida Antigen; Clostridium Botulinum Type A-Antitoxin; Etanercept(Tnfr : Fc) (CAS Number 185243-69- 0); Etesevimab (CAS Number 2423948-94-9); Gamma Globulin (CAS Number 9007-83-4); Granulocyte Colony Stimulating Factor (CAS Number 143011-72-7); Human Immunglobulin Anti-Hbs; Immunoglobulin Antihepatitis B; Immunoglobulin Human Anti-Tetanus; Immunoglobulin Human Normal; Immunoglobulin IgG2a; Immunoglobulin; Interferon Alfa; Interferon Alfa-2a (CAS Number 76543-88-9); Interferon Alfa-2b (CAS Number 98530-12-2); Interferon Beta; Interferon Beta-1a (CAS Number 145258-61-3); Interferon Lymphoblastoid Human; Interferon (CAS Number 9008-11-1); Intrinsic Factor (CAS number 9008-12-2); Iodinated (I-125) Fibrinogen; Lenograstim (CAS Number 135968-09-1); Methoxy Polyethylene Glycol Epoetin Beta (CAS Number 677324-53-7); Muromonab-Cd3 (CAS Number 140608-64-6); Peginterferon Alfa 2a (CAS Number 198153-51-4); Peg-Interferon Alfa-2b (CAS Number 215647-85-1); Pertactin (CAS Number 148374-88-3); Proteus Antigen; Rabies Antiserum; Rabies Imunoglobuline; Ranibizumab (CAS Number 347396-82-1); Regdanvimab (CAS Number 2444308-95-4); Rituximab (CAS Number 174722-31-7); Thrombin (CAS Number 9002-04-4); Thymosin Alpha-1 (CAS Number 62304-98-7); Trastuzumab (CAS Number 180288-69-1); Trichophyt Antigen; Tuberculin Ppd; Erenumab (CAS Number 1582205-90-0); Denosumab (CAS Number 615258-40-7); Obinutuzumab (CAS Number 949142-50-1); Triptorelin Acetate (CAS Number 140194-24-7); Eptinezumab (CAS Number 1644539-04-7); Evolocumab (CAS Number 1256937-27-5); Faricimab (CAS Number 1607793-29-2); Casirivimab (CAS Number 2415933-42-3); Serplulimab (CAS Number 2231029-82-4)
(KH.5, KH.7, KH.14, KH.17 atau KH.9a)
Darah Manusia; Darah Hewan Disiapkan Untuk Keperluan Terapeutik, Profilaktik Atau Diagnosis; Antiserum, Bagian Darah Dan Produk Imunologi Lainnya, Dimodifikasi Maupun Tidak Atau Diperoleh Dengan Proses Bioteknologi Maupun Tidak; Vaksin, Toksin, Kultur Dar
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Produk imunologi, tidak dicampur, tidak disiapkan dalam dosis atau bentuk atau kemasan untuk penjualan eceran : Alpha Globulins (CAS Number 9006-79-5); Anti-Lymphocyte Immunoglobulin (Horse); Anti-Thymocyt Igg-Globulin (H[St) (CAS Number 308067-60-9); Basiliximabum (CAS Number 179045-86-4); Bevacizumab (CAS Number 216974-75-3); Bamlanivimab (CAS Number 2423943-37-5); Candida Antigen; Clostridium Botulinum Type A-Antitoxin; Etanercept(Tnfr : Fc) (CAS Number 185243-69- 0); Etesevimab (CAS Number 2423948-94-9); Gamma Globulin (CAS Number 9007-83-4); Granulocyte Colony Stimulating Factor (CAS Number 143011-72-7); Human Immunglobulin Anti-Hbs; Immunoglobulin Antihepatitis B; Immunoglobulin Human Anti-Tetanus; Immunoglobulin Human Normal; Immunoglobulin IgG2a; Immunoglobulin; Interferon Alfa; Interferon Alfa-2a (CAS Number 76543-88-9); Interferon Alfa-2b (CAS Number 98530-12-2); Interferon Beta; Interferon Beta-1a (CAS Number 145258-61-3); Interferon Lymphoblastoid Human; Interferon (CAS Number 9008-11-1); Intrinsic Factor (CAS number 9008-12-2); Iodinated (I-125) Fibrinogen; Lenograstim (CAS Number 135968-09-1); Methoxy Polyethylene Glycol Epoetin Beta (CAS Number 677324-53-7); Muromonab-Cd3 (CAS Number 140608-64-6); Peginterferon Alfa 2a (CAS Number 198153-51-4); Peg-Interferon Alfa-2b (CAS Number 215647-85-1); Pertactin (CAS Number 148374-88-3); Proteus Antigen; Rabies Antiserum; Rabies Imunoglobuline; Ranibizumab (CAS Number 347396-82-1); Regdanvimab (CAS Number 2444308-95-4); Rituximab (CAS Number 174722-31-7); Thrombin (CAS Number 9002-04-4); Thymosin Alpha-1 (CAS Number 62304-98-7); Trastuzumab (CAS Number 180288-69-1); Trichophyt Antigen; Tuberculin Ppd; Erenumab (CAS Number 1582205-90-0); Denosumab (CAS Number 615258-40-7); Obinutuzumab (CAS Number 949142-50-1); Triptorelin Acetate (CAS Number 140194-24-7); Eptinezumab (CAS Number 1644539-04-7); Evolocumab (CAS Number 1256937-27-5); Faricimab (CAS Number 1607793-29-2); Casirivimab (CAS Number 2415933-42-3); Serplulimab (CAS Number 2231029-82-4)
(KH.5, KH.7, KH.14, KH.17 atau KH.9a)
Darah Manusia; Darah Hewan Disiapkan Untuk Keperluan Terapeutik, Profilaktik Atau Diagnosis; Antiserum, Bagian Darah Dan Produk Imunologi Lainnya, Dimodifikasi Maupun Tidak Atau Diperoleh Dengan Proses Bioteknologi Maupun Tidak; Vaksin, Toksin, Kultur Dar
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Produk imunologi, tidak dicampur, tidak disiapkan dalam dosis atau bentuk atau kemasan untuk penjualan eceran : Alpha Globulins (CAS Number 9006-79-5); Anti-Lymphocyte Immunoglobulin (Horse); Anti-Thymocyt Igg-Globulin (H[St) (CAS Number 308067-60-9); Basiliximabum (CAS Number 179045-86-4); Bevacizumab (CAS Number 216974-75-3); Bamlanivimab (CAS Number 2423943-37-5); Candida Antigen; Clostridium Botulinum Type A-Antitoxin; Etanercept(Tnfr : Fc) (CAS Number 185243-69- 0); Etesevimab (CAS Number 2423948-94-9); Gamma Globulin (CAS Number 9007-83-4); Granulocyte Colony Stimulating Factor (CAS Number 143011-72-7); Human Immunglobulin Anti-Hbs; Immunoglobulin Antihepatitis B; Immunoglobulin Human Anti-Tetanus; Immunoglobulin Human Normal; Immunoglobulin IgG2a; Immunoglobulin; Interferon Alfa; Interferon Alfa-2a (CAS Number 76543-88-9); Interferon Alfa-2b (CAS Number 98530-12-2); Interferon Beta; Interferon Beta-1a (CAS Number 145258-61-3); Interferon Lymphoblastoid Human; Interferon (CAS Number 9008-11-1); Intrinsic Factor (CAS number 9008-12-2); Iodinated (I-125) Fibrinogen; Lenograstim (CAS Number 135968-09-1); Methoxy Polyethylene Glycol Epoetin Beta (CAS Number 677324-53-7); Muromonab-Cd3 (CAS Number 140608-64-6); Peginterferon Alfa 2a (CAS Number 198153-51-4); Peg-Interferon Alfa-2b (CAS Number 215647-85-1); Pertactin (CAS Number 148374-88-3); Proteus Antigen; Rabies Antiserum; Rabies Imunoglobuline; Ranibizumab (CAS Number 347396-82-1); Regdanvimab (CAS Number 2444308-95-4); Rituximab (CAS Number 174722-31-7); Thrombin (CAS Number 9002-04-4); Thymosin Alpha-1 (CAS Number 62304-98-7); Trastuzumab (CAS Number 180288-69-1); Trichophyt Antigen; Tuberculin Ppd; Erenumab (CAS Number 1582205-90-0); Denosumab (CAS Number 615258-40-7); Obinutuzumab (CAS Number 949142-50-1); Triptorelin Acetate (CAS Number 140194-24-7); Eptinezumab (CAS Number 1644539-04-7); Evolocumab (CAS Number 1256937-27-5); Faricimab (CAS Number 1607793-29-2); Casirivimab (CAS Number 2415933-42-3); Serplulimab (CAS Number 2231029-82-4)
(KH.5, KH.7, KH.14, KH.17 atau KH.9a)
Darah Manusia; Darah Hewan Disiapkan Untuk Keperluan Terapeutik, Profilaktik Atau Diagnosis; Antiserum, Bagian Darah Dan Produk Imunologi Lainnya, Dimodifikasi Maupun Tidak Atau Diperoleh Dengan Proses Bioteknologi Maupun Tidak; Vaksin, Toksin, Kultur Dar
同一 HS 6 位前缀 3002.13 在其他国家的税率对照